{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:18:31Z","timestamp":1783012711115,"version":"3.54.6"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11934-018-0863-3","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T04:47:32Z","timestamp":1541738852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases"],"prefix":"10.1007","volume":"19","author":[{"given":"Gregory A.","family":"Joice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip M.","family":"Pierorazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,9]]},"reference":[{"key":"863_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. Cancer J Clin [Internet]. 2018 [cited 2018 Jun 10];68(1):7\u201330. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29313949 .","DOI":"10.3322\/caac.21442"},{"issue":"24","key":"863_CR2","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1200\/JCO.2005.08.227","volume":"23","author":"KA McGlynn","year":"2005","unstructured":"McGlynn KA, Devesa SS, Graubard BI, Castle PE. Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol. 2005;23(24):5757\u201361.","journal-title":"J Clin Oncol"},{"issue":"9","key":"863_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1464-410X.2005.05504.x","volume":"95","author":"TB Powles","year":"2005","unstructured":"Powles TB, Bhardwa J, Shamash J, Mandalia S, Oliver T. The changing presentation of germ cell tumours of the testis between 1983 and 2002. BJU Int. 2005;95(9):1197\u2013200.","journal-title":"BJU Int"},{"key":"863_CR4","unstructured":"Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, et al. SEER cancer statistics review, 1975-2015. Bethesda, MD: National Cancer Institute. https:\/\/seer.cancer.gov\/csr\/1975_2"},{"key":"863_CR5","unstructured":"Stephenson AJ, Gilligan TD. Neoplasms of the Testis. Campbell-Walsh Urology 11th Edition:34:784\u2013814."},{"issue":"1","key":"863_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0090-4295(94)80002-2","volume":"44","author":"J Sheinfeld","year":"1994","unstructured":"Sheinfeld J. Nonseminomatous germ cell tumors of the testis: current concepts and controversies. Urology. 1994;44(1):2\u201314.","journal-title":"Urology"},{"key":"863_CR7","unstructured":"Gilligan T, Beard C, Chism D, Cost N, Derweesh IH, Emamekhoo H, et al. NCCN Guidelines Version 2.2018 Testicular Cancer NCCN Guidelines 2018 Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/testicular.pdf"},{"issue":"6","key":"863_CR8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2214\/AJR.12.10319","volume":"200","author":"EI Kreydin","year":"2013","unstructured":"Kreydin EI, Barrisford GW, Feldman AS, Preston MA. Testicular cancer: what the radiologist needs to know. Am J Roentgenol. 2013;200(6):1215\u201325.","journal-title":"Am J Roentgenol"},{"issue":"2","key":"863_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2214\/ajr.169.2.9242768","volume":"169","author":"S Hilton","year":"1997","unstructured":"Hilton S, Herr HW, Teitcher JB, Begg CB, Cast\u00e9llino RA. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol. 1997;169(2):521\u20135.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"863_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/1066896911431452","volume":"20","author":"T Hudolin","year":"2012","unstructured":"Hudolin T, Kastelan Z, Knezevic N, Goluza E, Tomas D, Coric M. Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors. Int J Surg Pathol. 2012;20(1):15\u20138.","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"863_CR11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0022-5347(17)39044-4","volume":"142","author":"SD Foss\u00e5","year":"1989","unstructured":"Foss\u00e5 SD, Aass N, Ous S, H\u00f8ie J, Stenwig AE, Lien HH, et al. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. J Urol. 1989;142(5):1239\u201342.","journal-title":"J Urol"},{"issue":"5","key":"863_CR12","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1200\/JCO.1995.13.5.1177","volume":"13","author":"EW Steyerberg","year":"1995","unstructured":"Steyerberg EW, Keizer HJ, Foss\u00e5 SD, Sleijfer DT, Toner GC, Schraffordt Koops H, et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol. 1995;13(5):1177\u201387.","journal-title":"J Clin Oncol"},{"key":"863_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1148\/radiology.215.2.r00ma02437","volume":"2","author":"EW Steyerberg","year":"2000","unstructured":"Steyerberg EW, Keizer HJ, Sleijfer DT, Foss\u00e5 SD, Bajorin DF, Gerl A, et al. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy. Radiology. 2000;2:437\u201344.","journal-title":"Radiology"},{"issue":"4","key":"863_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00004728-198408000-00023","volume":"8","author":"JH Ellis","year":"1984","unstructured":"Ellis JH, Bies JR, Kopecky KK, Klatte EC, Rowland RG, Donohue JP. Comparison of NMR and CT imaging in the evaluation of metastatic retroperitoneal lymphadenopathy from testicular carcinoma. J Comput Assist Tomogr. 1984;8(4):709\u201319.","journal-title":"J Comput Assist Tomogr"},{"issue":"10","key":"863_CR15","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3109\/0284186X.2015.1043027","volume":"54","author":"F Mosavi","year":"2015","unstructured":"Mosavi F, Laurell A, Ahlstr\u00f6m H. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer. Acta Oncol. 2015;54(10):1763\u20139.","journal-title":"Acta Oncol"},{"issue":"5","key":"863_CR16","first-page":"429","volume":"19","author":"WR Hogeboom","year":"1993","unstructured":"Hogeboom WR, Hoekstra HJ, Mooyaart EL, Sleijfer DT, Schraffordt KH. Magnetic resonance imaging of retroperitoneal lymph node metastases of non-seminomatous germ cell tumours of the testis. Eur J Surg Oncol. 1993;19(5):429\u201337.","journal-title":"Eur J Surg Oncol"},{"key":"863_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.crad.2008.10.011","volume":"4","author":"SA Sohaib","year":"2009","unstructured":"Sohaib SA, Koh DM, Barbachano Y, Parikh J, Husband JES, Dearnaley DP, et al. Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours. Clin Radiol. 2009;4:362\u20137.","journal-title":"Clin Radiol"},{"issue":"13","key":"863_CR18","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1200\/JCO.2008.18.8953","volume":"27","author":"T Tandstad","year":"2009","unstructured":"Tandstad T, Dahl O, Cohn-Cedermark G, Cavallin-Stahl E, Stierner U, Solberg A, et al. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program. J Clin Oncol. 2009;27(13):2122\u20138.","journal-title":"J Clin Oncol"},{"issue":"6","key":"863_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.eururo.2017.12.030","volume":"73","author":"PM Pierorazio","year":"2018","unstructured":"Pierorazio PM, Albers P, Black PC, Tandstad T, Heidenreich A, Nicolai N, et al. Non\u2013risk-adapted surveillance for stage I testicular cancer: critical review and summary. Eur Urol. 2018;73(6):899\u2013907.","journal-title":"Eur Urol"},{"issue":"1","key":"863_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1102\/1470-7330.2006.0020","volume":"6","author":"PU Dalal","year":"2006","unstructured":"Dalal PU, Sohaib SA, Huddart R. Imaging of testicular germ cell tumours. Cancer Imaging. 2006;6(1):124\u201334.","journal-title":"Cancer Imaging"},{"issue":"13","key":"863_CR21","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2217\/fon.14.87","volume":"10","author":"C Nanni","year":"2014","unstructured":"Nanni C, Zanoni L, Fanti S. Nuclear medicine in urological cancers: what is new? Future Oncol. 2014;10(13):2061\u201372.","journal-title":"Future Oncol"},{"key":"863_CR22","doi-asserted-by":"crossref","unstructured":"Huddart RA, Doherty MJO, Padhani A, Rustin GJS, Mead GM, Joffe JK, et al. Fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk , clinical stage I nonseminomatous germ cell tumors : preliminary report of MRC Trial TE22 \u2014 the NCRI Testis Tumour Clinical Study Group. J Clin Oncol 2007;25(21).","DOI":"10.1200\/JCO.2006.09.3831"},{"key":"863_CR23","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/annonc\/mdn170","volume":"19","author":"M Wit De","year":"2008","unstructured":"De Wit M, Brenner W, Hartmann M, Kotzerke J, Hellwig D, Lehmann J, et al. [18F]-FDG-PET in clinical stage I\/II non-seminomatous germ cell tumours: results of the German multicentre trial. Ann Oncol. 2008;19:1619\u201323.","journal-title":"Ann Oncol"},{"issue":"4","key":"863_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00259-013-2624-3","volume":"41","author":"V Ambrosini","year":"2014","unstructured":"\u2022 Ambrosini V, Zucchini G, Nicolini S, Berselli A, Nanni C, Allegri V, et al. 18F-FDG PET\/CT impact on testicular tumours clinical management. Eur J Nucl Med Mol Imaging. 2014;41(4):668\u201373 Important series of patients studying performance characteristics of FDG PET in staging and restaging setting and determining clinical impact.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"863_CR25","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1200\/JCO.2004.07.188","volume":"22","author":"M Santis De","year":"2004","unstructured":"De Santis M, Becherer A, Bokemeyer C, Stoiber F, Oechsle K, Sellner F, et al. 2- 18 fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET Trial. J Clin Oncol. 2004;22(6):1034\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"863_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/annonc\/mdr052","volume":"23","author":"M Bachner","year":"2012","unstructured":"Bachner M, Loriot Y, Gross-Goupil M, Zucali PA, Horwich A, Germa-Lluch J-R, et al. 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. Ann Oncol. 2012;23(1):59\u201364.","journal-title":"Ann Oncol"},{"key":"863_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/852681","volume":"2014","author":"Giorgio Treglia","year":"2014","unstructured":"Treglia G, Sadeghi R, Annunziata S, Caldarella C, Bertagna F, Giovanella L. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis. Biomed Res Int 2014:852681.","journal-title":"BioMed Research International"},{"issue":"3","key":"863_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.clgc.2015.08.010","volume":"14","author":"A Necchi","year":"2016","unstructured":"Necchi A, Nicolai N, Alessi A, Miceli R, Giannatempo P, Raggi D, et al. Interim 18F-Fluorodeoxyglucose positron emission tomography for early metabolic assessment of response to cisplatin, etoposide, and bleomycin chemotherapy for metastatic seminoma: clinical value and future directions. Clin Genitourin Cancer. 2016;14(3):249\u201354.","journal-title":"Clin Genitourin Cancer"},{"issue":"36","key":"863_CR29","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.1200\/JCO.2008.17.1157","volume":"26","author":"K Oechsle","year":"2008","unstructured":"Oechsle K, Hartmann M, Brenner W, Venz S, Weissbach L, Franzius C, et al. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group. J Clin Oncol. 2008;26(36):5930\u20135.","journal-title":"J Clin Oncol"},{"issue":"3","key":"863_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cpet.2015.03.002","volume":"10","author":"K Bouchelouche","year":"2015","unstructured":"Bouchelouche K, Choyke PL. PET\/computed tomography in renal, bladder, and testicular cancer. PET Clin. 2015;10(3):361\u201374.","journal-title":"PET Clin"},{"issue":"11","key":"863_CR31","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/3337","volume":"4","author":"AF Shields","year":"1998","unstructured":"Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4(11):1334\u20136.","journal-title":"Nat Med"},{"issue":"9","key":"863_CR32","first-page":"1426","volume":"44","author":"AK Buck","year":"2003","unstructured":"Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med. 2003;44(9):1426\u201331.","journal-title":"J Nucl Med"},{"key":"863_CR33","first-page":"988","volume":"7","author":"DL Francis","year":"2003","unstructured":"Francis DL, Visvikis D, Costa DC, Arulampalam THA, Townsend C, Luthra SK, et al. Potential impact of [18F]3\u2032-deoxy-3\u2032-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. Eur J Nucl Med Mol Imaging. 2003;7:988\u201394.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"863_CR34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2967\/jnumed.109.070425","volume":"51","author":"C Pfannenberg","year":"2010","unstructured":"Pfannenberg C, Aschoff P, Dittmann H, Mayer F, Reischl G, von Weyhern C, et al. PET\/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors? J Nucl Med. 2010;51(6):845\u201353.","journal-title":"J Nucl Med"},{"issue":"5","key":"863_CR35","first-page":"815","volume":"39","author":"U Cremerius","year":"1998","unstructured":"Cremerius U, Effert PJ, Adam G, Sabri O, Zimmy M, Wagenknecht G, et al. FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med. 1998;39(5):815\u201322.","journal-title":"J Nucl Med"},{"issue":"7","key":"863_CR36","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1054\/bjoc.2000.1389","volume":"83","author":"SF Hain","year":"2000","unstructured":"Hain SF, O\u2019Doherty MJ, Timothy AR, Leslie MD, Harper PG, Huddart RA. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer. 2000;83(7):863\u20139.","journal-title":"Br J Cancer"},{"issue":"1040","key":"863_CR37","doi-asserted-by":"publisher","first-page":"20140263","DOI":"10.1259\/bjr.20140263","volume":"87","author":"P Sharma","year":"2014","unstructured":"\u2022\u2022 Sharma P, Jain TK, Parida GK, Karunanithi S, Patel C, Sharma A, et al. Diagnostic accuracy of integrated 18 F-FDG PET\/CT for restaging patients with malignant germ cell tumours. Br J Radiol. 2014;87(1040):20140263 Interesting study assessing FDG PET in the work up of recurrent GCT revealing potential role for PET in setting of negative conventional imaging.","journal-title":"Br J Radiol"},{"issue":"1","key":"863_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00259-017-3811-4","volume":"45","author":"P Alongi","year":"2018","unstructured":"\u2022 Alongi P, Evangelista L, Caobelli F, Spallino M, Gianolli L, Midiri M, et al. Diagnostic and prognostic value of 18F-FDG PET\/CT in recurrent germinal tumor carcinoma. Eur J Nucl Med Mol Imaging. 2018;45(1):85\u201394 Larger study revealing high accuracy of FDG PET imaging in detecting metastatic lymph nodes during suspected GCT recurrence.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"863_CR39","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1200\/JCO.2005.07.166","volume":"23","author":"AG Rockall","year":"2005","unstructured":"Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR, et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol. 2005;23(12):2813\u201321.","journal-title":"J Clin Oncol"},{"key":"863_CR40","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1148\/radiol.2283020872","volume":"3","author":"Y Anzai","year":"2003","unstructured":"Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, et al. Evaluation of neck and body metastases to nodes with Ferumoxtran 10\u2013enhanced MR imaging: phase III safety and efficacy study. Radiology. 2003;3:777\u201388.","journal-title":"Radiology"},{"issue":"1","key":"863_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1148\/radiol.2311030142","volume":"231","author":"D-M Koh","year":"2004","unstructured":"Koh D-M, Brown G, Temple L, Raja A, Toomey P, Bett N, et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings\u2014initial observations. Radiology. 2004;231(1):91\u20139.","journal-title":"Radiology"},{"issue":"2","key":"863_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00261-001-0182-9","volume":"28","author":"M-F Bellin","year":"2003","unstructured":"Bellin M-F, Lebleu L, Meric J-B. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging. 2003;28(2):155\u201363.","journal-title":"Abdom Imaging"},{"key":"863_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0720-048X(00)00204-7","volume":"34","author":"M-F Bellin","year":"2000","unstructured":"Bellin M-F, Beigelman C, Precetti-Morel S. Iron oxide-enhanced MR lymphography: initial experience. Eur J Radiol. 2000;34:257\u201364.","journal-title":"Eur J Radiol"},{"issue":"2","key":"863_CR44","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ejrad.2009.11.027","volume":"80","author":"L Wu","year":"2011","unstructured":"Wu L, Cao Y, Liao C, Huang J, Gao F. Diagnostic performance of USPIO-enhanced MRI for lymph-node metastases in different body regions: a meta-analysis. Eur J Radiol. 2011;80(2):582\u20139.","journal-title":"Eur J Radiol"},{"key":"863_CR45","doi-asserted-by":"publisher","unstructured":"Lebastchi AH, Watson MJ, Russell CM, George AK, Weizer AZ, Turkbey B. Using imaging to predict treatment response in genitourinary malignancies. Eur Urol Focus 2017. https:\/\/doi.org\/10.1016\/j.euf.2017.09.003","DOI":"10.1016\/j.euf.2017.09.003"},{"issue":"1","key":"863_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2214\/AJR.04.1287","volume":"186","author":"MG Harisinghani","year":"2006","unstructured":"Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi MT, et al. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? Am J Roentgenol. 2006;186(1):144\u20138.","journal-title":"Am J Roentgenol"},{"issue":"5","key":"863_CR47","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2214\/ajr.172.5.10227514","volume":"172","author":"MG Harisinghani","year":"1999","unstructured":"Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, et al. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. Am J Roentgenol. 1999;172(5):1347\u201351.","journal-title":"Am J Roentgenol"},{"issue":"5","key":"863_CR48","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.urology.2005.05.049","volume":"66","author":"MG Harisinghani","year":"2005","unstructured":"Harisinghani MG, Saksena M, Ross RW, Tabatabaei S, Dahl D, McDougal S, et al. A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. Urology. 2005;66(5):1066\u201371.","journal-title":"Urology"},{"issue":"1","key":"863_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S1470-2045(05)70537-4","volume":"7","author":"O Will","year":"2006","unstructured":"Will O, Purkayastha S, Chan C, Athanasiou T, Darzi AW, Gedroyc W, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol. 2006;7(1):52\u201360.","journal-title":"Lancet Oncol"},{"issue":"25","key":"863_CR50","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1056\/NEJMoa022749","volume":"348","author":"MG Harisinghani","year":"2003","unstructured":"Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348(25):2491\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"863_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrurol.2016.26","volume":"13","author":"T Maurer","year":"2016","unstructured":"Maurer T, Eiber M, Schwaiger M, Gschwend JE. Current use of PSMA\u2013PET in prostate cancer management. Nat Rev Urol. 2016;13(4):226\u201335.","journal-title":"Nat Rev Urol"},{"issue":"10","key":"863_CR52","first-page":"145","volume":"3","author":"G Savelli","year":"2015","unstructured":"Savelli G, Muni A, Falchi R, Zaniboni A, Barbieri R, Valmadre G, et al. Somatostatin receptors over-expression in castration resistant prostate cancer detected by PET\/CT: preliminary report of in six patients. Ann Transl Med. 2015;3(10):145.","journal-title":"Ann Transl Med"},{"issue":"5","key":"863_CR53","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/RLU.0000000000001618","volume":"42","author":"S Usmani","year":"2017","unstructured":"Usmani S, Ahmed N, Marafi F, Rasheed R, Amanguno HG, Al KF. Molecular imaging in neuroendocrine differentiation of prostate cancer: 68Ga-PSMA versus 68Ga-DOTA NOC PET-CT. Clin Nucl Med. 2017;42(5):410\u20133.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"863_CR54","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/jc.2003-031375","volume":"89","author":"F Gaytan","year":"2004","unstructured":"Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herington AC, Morales C, et al. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab. 2004;89(1):400\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"863_CR55","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.1021\/acs.jmedchem.7b00164","volume":"60","author":"CL Charron","year":"2017","unstructured":"Charron CL, Hou J, McFarland MS, Dhanvantari S, Kovacs MS, Luyt LG. Structure\u2212activity study of ghrelin(1\u22128) resulting in high affinity fluorine-bearing ligands for the ghrelin receptor. J Med Chem. 2017;60:7256\u201366.","journal-title":"J Med Chem"},{"key":"863_CR56","doi-asserted-by":"publisher","first-page":"232.e15","DOI":"10.1016\/j.urology.2011.03.004","volume":"78","author":"FJ Penna","year":"2011","unstructured":"Penna FJ, Freilich DA, Alvarenga C, Nguyen HT. Improving lymph node yield in retroperitoneal lymph node dissection using fluorescent molecular imaging: a novel method of localizing lymph nodes in guinea pig model. Urology. 2011;78:232.e15\u20138.","journal-title":"Urology"},{"issue":"4","key":"863_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11934-015-0495-9","volume":"16","author":"MA Bjurlin","year":"2015","unstructured":"Bjurlin MA, McClintock TR, Stifelman MD. Near-infrared fluorescence imaging with intraoperative administration of indocyanine green for robotic partial nephrectomy. Curr Urol Rep. 2015;16(4):20.","journal-title":"Curr Urol Rep"},{"issue":"5","key":"863_CR58","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.juro.2016.05.087","volume":"196","author":"M Ram\u00edrez-Backhaus","year":"2016","unstructured":"Ram\u00edrez-Backhaus M, Mira Moreno A, G\u00f3mez Ferrer A, Calatrava Fons A, Casanova J, Solsona Narb\u00f3n E, et al. Indocyanine green guided pelvic lymph node dissection: an efficient technique to classify the lymph node status of patients with prostate cancer who underwent radical prostatectomy. J Urol. 2016;196(5):1429\u201335.","journal-title":"J Urol"},{"issue":"17","key":"863_CR59","first-page":"30114","volume":"S2405\u20134569","author":"MCH Hekman","year":"2017","unstructured":"Hekman MCH, Rijpkema M, Langenhuijsen JF, Boerman OC, Oosterwijk E, Mulders PFA. Intraoperative imaging techniques to support complete tumor resection in partial nephrectomy. Eur Urol Focus. 2017;S2405\u20134569(17):30114\u20131.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"863_CR60","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.eururo.2016.06.012","volume":"72","author":"NS Berg van den","year":"2017","unstructured":"van den Berg NS, Buckle T, KleinJan GH, van der Poel HG, van Leeuwen FWB. Multispectral fluorescence imaging during robot-assisted laparoscopic sentinel node biopsy: a first step towards a fluorescence-based anatomic roadmap. Eur Urol. 2017;72(1):110\u20137.","journal-title":"Eur Urol"},{"issue":"1","key":"863_CR61","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.clgc.2016.09.007","volume":"15","author":"L Xia","year":"2018","unstructured":"Xia L, Venegas OG, Predina JD, Singhal S, Guzzo TJ. Intraoperative molecular imaging for post-chemotherapy robot-assisted laparoscopic resection of seminoma metastasis: a case report. Clin Genitourin Cancer. 2018;15(1):61\u20134.","journal-title":"Clin Genitourin Cancer"},{"key":"863_CR62","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2967\/jnumed.109.071779","volume":"3","author":"L Vermeeren","year":"2010","unstructured":"Vermeeren L, Meinhardt W, Bex A, van der Poel HG, Vogel WV, Hoefnagel CA, et al. Paraaortic sentinel lymph nodes: toward optimal detection and intraoperative localization using SPECT\/CT and intraoperative real-time imaging. J Nucl Med. 2010;3:376\u201382.","journal-title":"J Nucl Med"},{"issue":"7","key":"863_CR63","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00259-009-1100-6","volume":"36","author":"L Vermeeren","year":"2009","unstructured":"Vermeeren L, Vald\u00e9s Olmos RA, Meinhardt W, Bex A, van der Poel HG, Vogel WV, et al. Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies. Eur J Nucl Med Mol. 2009;36(7):1029\u201336.","journal-title":"Eur J Nucl Med Mol"},{"issue":"4","key":"863_CR64","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2967\/jnumed.110.086660","volume":"52","author":"OR Brouwer","year":"2011","unstructured":"Brouwer OR, Valdes Olmos RA, Vermeeren L, Hoefnagel CA, Nieweg OE, Horenblas S. SPECT\/CT and a portable -camera for image-guided laparoscopic sentinel node biopsy in testicular cancer. J Nucl Med. 2011;52(4):551\u20134.","journal-title":"J Nucl Med"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-018-0863-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-018-0863-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-018-0863-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T17:12:22Z","timestamp":1662397942000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-018-0863-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,9]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["863"],"URL":"https:\/\/doi.org\/10.1007\/s11934-018-0863-3","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,9]]},"assertion":[{"value":"9 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Gregory A. Joice, Steven P. Rowe, Michael A. Gorin, and Phillip M. Pierorazio each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"110"}}